For third-quarter 2011, Riber S.A. of Bezons, France, which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources and effusion cells, has reported revenue of €5.5m, up 72% on €3.2m a year ago.
Following €5.7m in Q1 and €7.2m in Q2, revenue for the first three quarters of 2011 totaled €18.5m (55% from Asia, 35% from Europe, and 10% from North America), up 142% on just €7.6m a year ago.
During the first three quarters, growth was driven primarily by sales of evaporation sources, up14-fold year-on-year from just €0.6m to €9.1m, reflecting the delivery of major orders for investments in the organic LED (OLED) flat-screen markets. Systems sales more than doubled, from €2.8m to €5.7m, as five MBE systems were delivered, compared with four research systems a year ago (with a marked improvement in their unit value). However, revenue from services and accessories fell by 12%, from €4.2m to €3.7m, due to demand slowing, particularly in the USA.
The order book totaled €19.3m at the end of September (compared with €19.1m a year ago), including three production systems and seven research systems (to be delivered between 2011 and 2013).
In view of the delivery schedule for the end of the year, Riber is targeting about €29m in full-year 2011 revenue, up 40% on 2010’s €20.7m (compared with July’s forecast of €27–29m, up 35%), combined with an operating margin of more than 15%. Riber will report full-year revenue on 17 January 2012.